NetworkNewsBreaks Archive - Page 2070 of 2139

FridayMar 24, 2017 11:21 am

NetworkNewsBreaks – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Issued ‘Buy’ Rating, $8 PT at Aegis Capital

Aegis Capital has issued a ‘Buy’ rating and price target of $8 on shares of Ritter Pharmaceuticals (NASDAQ: RTTR). The company recently modified the primary endpoint of its phase 2b/3 clinical trial of RP-G28, following a meeting with the FDA, in hopes of being considered as a pivotal trial, which would shorten the time frame to approval and revenues. The report by Aegis cites the anticipated release of results from the phase 2b/3 clinical trial of RP-G28, which is expected by the end of the month. For more information, visit www.ritterpharma.com About Ritter Pharmaceuticals Ritter Pharmaceuticals, Inc. develops novel therapeutic products…

FridayMar 24, 2017 11:18 am

NetworkNewsBreaks – Xenon Pharmaceuticals, Inc. (NASDAQ: XENE) Shares Dive; XEN801 Disappoints in Phase 2 Clinical Trial

Shares of Xenon Pharmaceuticals (NASDAQ: XENE) are down 51% after the company reported topline efficacy results from the phase 2 clinical trial to evaluate the efficacy, safety, tolerability and systemic exposure of XEN801 for the treatment of moderate to severe facial acne. Trial results show that XEN801 did not demonstrate a statistically significant difference from vehicle placebo in its primary endpoint of the percent change in total lesion count from baseline to week 12. Results also show that XEN801 did not demonstrate statistical significance relative to key secondary efficacy endpoints. “Despite the good scientific and preclinical rationale to pursue SCD1…

FridayMar 24, 2017 11:15 am

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating, $11 PT on ViewRay, Inc. (NASDAQ: VRAY)

Aegis Capital has reiterated its ‘Buy’ rating and price target of $11 on shares of ViewRay, Inc. (NASDAQ: VRAY). The action follows the release of ViewRay’s financial results, including fourth-quarter 2016 revenue of $16.1 million. Operating costs for the quarter were $9.3 million, down from $10.7 million for the fourth quarter of 2015. ViewRay also provided an outlook for 2017, including an update on the MRIdian LINAC system. The company reported a clear increase in interest in the system after receiving FDA approval in February. Orders are anticipated to further increase in 2017, driving revenue for the year. For more…

ThursdayMar 23, 2017 2:52 pm

NetworkNewsBreaks – MGX Minerals, Inc. (MGXMF) Enters Agreement to Acquire Working Interest in Paradox Basin

Diversified mining company MGX Minerals, Inc. (OTC: MGXMF) today announced its entry into a joint operating agreement with a private vendor to act as operator and acquire a 75 percent working interest in certain underlying oil and gas leases located contiguous to MGX’s Lisbon Valley petrolithium project. The agreement calls for payments totaling $2 million due on or before September 1, 2018. An accelerated payment schedule reflecting discounted payments is also outlined in the agreement terms. Per the news release, the related leases cover portions of San Juan County, Utah, and San Miguel County, Colorado, including access to the brine-bearing…

ThursdayMar 23, 2017 1:41 pm

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Reports Record Sales for Fiscal Quarter Ended January 31, 2017

Education technology company ProBility Media Corp. (OTCQB: PBYA) today announced its filing of Form 10-Q for its fiscal first quarter ended January 31, 2017. Notably, the company achieved its third consecutive quarter of year-over-year revenue growth, reporting a 13 percent year-over-year increase to $1 million for the three-month period. “We would like to congratulate and thank the ProBility team for continuing to hit record sales, in addition to many other extraordinary accomplishments achieved over the last year,” Evan Levine, Noah Davis and Steven Plumb, executive management of ProBility Media, noted in a joint statement in the news release. “Through enthusiastic…

ThursdayMar 23, 2017 12:59 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 23, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: HTGM 97.20% – News: Moving on momentum from recently obtaining CE marking in the EU for its HTG EdgeSeq ALKPlus Assay EU BDCI 19.57% – News: Issues update on Native Outfitters™ and Freeport MNTM 15.36% – News: Receives key patent for TAM-01 from Japanese Patent Office CGIX 14.66% – News: Posts Q4, FY 2016 results AFMD 9.57% – News: Hosting conference call and releasing Q4, FY 2016 results on March 30 SSH 8.07% –…

ThursdayMar 23, 2017 12:57 pm

NetworkNewsBreaks – Atossa Genetics, Inc. (NASDAQ: ATOS) Opens Enrollment in Study of Endoxifen; Shares Down

Shares of Atossa Genetics (NASDAQ: ATOS) are 10% lower after the company this morning said that it has opened enrollment of a phase 1 study of endoxifen. Endoxifen is an active metabolite of tamoxifen, an FDA-approved drug for breast cancer. The phase 1 study is a placebo-controlled, repeat dose study of 48 healthy female volunteers. The objective is to assess the pharmacokinetics of proprietary formulations of both oral and topical endoxifen dosage forms over 28 days, as well as to assess safety and tolerability. To view the full press release, visit: http://nnw.fm/1Z9Fg About Atossa Genetics Atossa Genetics Inc., is a…

ThursdayMar 23, 2017 12:55 pm

NetworkNewsBreaks – ImmuDyne, Inc. (IMMD) Shares Surge on Completed Formulation of Shapiro MD Product Line

ImmuDyne (OTCQB: IMMD) shares are 21.5% higher mid-day following early news that all formulation work has been completed on the Shapiro MD product line. The first product run will transpire in the next 2-3 weeks, and a national product launch is anticipated no later than April 15, 2017. The all natural and patented hair loss product line will include shampoo, conditioner, and a once-daily leave-in foam product. "We’re very excited for the product launch and are very optimistic that the 10 years we invested in research and development to create Shapiro MD will benefit people around the world that want…

ThursdayMar 23, 2017 12:53 pm

NetworkNewsBreaks – Egalet Corp. (NASDAQ: EGLT) Receives New U.S. and International Patents for Guardian™ Technology

Shares of Egalet (NASDAQ: EGLT) are up 4.5% mid-day on word the company has received new U.S. and international patents for its proprietary Guardian™ Technology, bringing the number to 18 U.S. patents and 95 international patents. The United States Patent and Trademark Office (USPTO) has issued a patent covering the company’s ARYMO™ ER extended-release tablets for oral use only. It is the second U.S. patent covering ARYMO ER and offers protection through 2033 and is listed in the Orange Book. A European patent has also been issued to Egalet and offers protection of products developed using Guardian Technology. Additionally, an…

ThursdayMar 23, 2017 12:50 pm

NetworkNewsBreaks – Sphere 3D Corp.’s (NASDAQ: ANY) HVE Solution Selected by The Beck Group for VDI; Shares Higher

Shares of Sphere 3D (NASDAQ: ANY) are trading higher after the company this morning said that The Beck Group has successfully employed an HVE solution for its Virtual Desktop Infrastructure (VDI), including VDI for GPU intensive workloads. The inclusion of the HVE 3DGFX appliances for running computer aided design (CAD) applications provides a powerful server-based computing environment for The Beck Group. The CAD data processed by the server provides a faster, more effective utilization of resources and enables staff to access their workloads from any device, anywhere. “We are delighted to have the opportunity to provide them with a high…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks